Abstract
Kelley-Seegmiller syndrome (KSS) is a disorder that occurs when there is a partial deficiency of the enzyme hypoxanthine guanine phosphoribosyl transferase. It is involved in the metabolism of purines, clinically manifesting as hyperuricemia, hyperuricosuria, gout arthritis, and urolithiasis. The aim of this article is to present the case of a 33-year-old male with KSS, with left ureteral colic, and a 5-mm, 323-HU ureteral calculi, successfully managed with conservative management. It is critical to recognize that most urologists are not familiar with this inborn metabolic error and 75% of these patients will be affected by urolithiasis, thus making it a very critical and significant disease in our practice.
References
1.
Moe OW, Abate N, Sakhaee K: Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31: 895–914.
2.
Torres RJ, Puig JG: Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J Rare Dis 2007; 2: 48.
3.
Monico CG, Milliner DS: Genetic determinants of urolithiasis. Nat Rev Nephrol 2012; 8: 151–162.
4.
Mateos FA, Puig JG: Purine metabolism in Lesch-Nyhan syndrome versus Kelley-Seegmiller syndrome. J Inherit Metab Dis 1994; 17: 138–142.
5.
Saigal R, Chakraborty A, Yadav RN, Prashant RK: Partial HPRT deficiency (Kelley-Seegmiller syndrome). J Assoc Physicians India 2006; 54: 49–52.
6.
Rodionovskaya SR, Zokirov NZ, Fedorov ES, Tsymbal IN, Salugina SO, Eliseev MS: Description Kelley-Seegmiller syndrome (partial HPRT deficiency manifesting as a gout-urolithiasis syndrome) in a patient of 15 years old. Pediatr Rheumatol 2011; 9(S1):P33.
7.
vorakova L, Hrebicek M, Minks J, Stolnaja L, Rychlik I: Unusual presentation of Kelley-Seegmiller syndrome. Nucleosides Nucleotides Nucleic Acids 2008; 27: 648–655.
8.
Cherian S, Crompton CH: Partial hypoxanthine-guanine phosphoribosyltransferase deficiency presenting as acute renal failure. Pediatr Nephrol 2005; 20: 1811–1813.
9.
Cossu A, Micheli V, Jacomelli G, Carcassi A: Kelley-Seegmiller syndrome in a patient with complete hypoxanthine-guanine phosphoribosyltransferase deficiency. Clin Exp Rheumatol 2002; 20: 851–853.
10.
Wein AJ, Kavoussi L, Partin A, Peters C: Urinary Lithiasis: Etiology, Epidemiology, and Pathogenesis. Campbell-Walsh Urology (ed 11). Elsevier, Inc, 2016, vol 51, pp 1170–1199.e9.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.